External quality assessment programmes for detection of HCV RNA, HIV RNA and HBV DNA in plasma: Improved proficiency of the participants observed over a 2-year period

Vox Sanguinis

Volumn 99, Issue 4, 2010, Pages 319-324

  Pisani, Giulio ^a   Cristiano, K ^a   Marino, F ^a   Luciani, F ^a   Bisso, G M ^a   Gaggioli, A ^a   Mele, C ^a   Pupella, S ^b   Grazzini, G ^b   Wirz, M ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b National Blood Center   (Italy)

Author keywords

Blood donations; Blood borne viruses; External quality assessment; Nucleic acid amplification techniques (NAT)

Indexed keywords

VIRUS DNA; VIRUS RNA;

ANALYTICAL ERROR; ARTICLE; AUTOMATION; BLOOD ANALYSIS; BLOOD BANK; BLOOD DONOR; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; LABORATORY DIAGNOSIS; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; QUALITY CONTROL; VIRAL CONTAMINATION;

BLOOD BANKS; DNA, VIRAL; FEMALE; HEPACIVIRUS; HEPATITIS B VIRUS; HIV; HUMANS; ITALY; MALE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; QUALITY ASSURANCE, HEALTH CARE; RNA, VIRAL; SENSITIVITY AND SPECIFICITY;

EID: 77958457235     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2010.01370.x     Document Type: Article

References (11)

1. Velati C, Romanò L, Fomiatti L, et al. : Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey, Transfusion, 2008; 48:2205-2213
2. Stramer SL, Glynn SA, Kleinman SH, et al. : Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing, N Engl J Med, 2004; 351:760-768
3. Laperche S: Blood safety and nucleic acid testing in Europe, Euro Surveill, 2005; 10:3-4
4. ILAC G13:2007 Guidelines for the Requirements for the Competence of Reference Materials Producers
5. Gentili G, Pisani G, Bisso G, et al. : Hepatitis C virus testing of plasma pools by nucleic acid amplification technology: external quality assessment, Vox Sang, 2001; 81:143-147
6. Pisani G, Cristiano K, Wirz M, et al. : Further evidence on the high proficiency of laboratories involved in plasma pool testing for HCV RNA by nucleic acid amplification technology, Vox Sang, 2002; 82(4):211-212
7. Gentili G, Pisani G, Saldanha J, et al. : High proficiency in detecting the six major hepatitis C virus genotypes of laboratories involved in testing plasma by nucleic acid amplification technology, Vox Sang, 2003; 85(2):114-116
8. Pisani G, Cristiano K, Saldanha J, et al. : External quality assessment for detection of blood-borne viruses in plasma by nucleic acid amplification technology: the first human immunodeficiency virus and hepatitis B virus studies (HIV EQA/1 and HBV EQA/1) and the fifth hepatitis C virus study (HCV EQA/5), Vox Sang, 2004; 87:91-95
9. Pisani G, Marino F, Cristiano K, et al. : External quality assessment for the detection of HCV RNA, HIV RNA and HBV DNA in plasma by nucleic acid amplification technology:a novel approach, Vox Sang, 2008; 95(1):8-12
10. Pisani G, Cristiano K, Marino F, et al. : Quantification of Hepatitis C Virus (HCV) RNA in a multicentre study: implications for management of HCV genotype 1-patients, J Clin Microbiol, 2009; 47(9):2931-2936
11. Dorn-Beineke A, Ahmad-Nejad P, Pfeiffer U, et al. : Improvement of technical and analytical performance in DNA sequencing by External Quality Assessment-based molecular training, Clin Chem, 2006; 52(11):2072-2078